Parexel Selects New Jersey Medical School as Alliance Site
Rutgers New Jersey Medical School’s designation as an alliance site by Parexel will give the school access to trial opportunities from Parexel’s clients.
The agreement will also allow Parexel to use the school’s facilities for early to late phase studies, and access to its electronic medical record system.
“Our collaboration with Parexel will further strengthen the capabilities of New Jersey Medical School’s clinical research center unit, which conducts clinical trials in a wide variety of medical specialties,” said William Gause, senior associate dean for research at NJMS, which on July 1 became part of the Rutgers Biomedical and Health Sciences unit. “With Parexel, NJMS looks forward to further developing our academic enterprise and biomedical research presence, as well as increasing patient recruitment and referrals.”
